165 University Ave, Suite 5,
Palo Alto, CA 94301
Quartz Therapeutics is an early stage biotech company focused on developing new small molecule inhibitors for RAS-driven cancers. Our founders include medicinal chemistry expert Robert Zamboni and world leading RAS expert Frank McCormick. We are currently in the hit to lead stage and plan to begin IND enabling studies in 2018.